Our Promise

DAVA Mission Statement

To improve patient care by realizing the full potential of oncology drug development.

DAVA Oncology was founded in 2007 with a mission to facilitate successful drug development. During our quest, we have created innovative solutions and services that have accelerated the clinical development process. We strive to meet your unmet needs through knowledge-based strategic consulting, accrual enhancement initiatives and medical oncology support.

With our knowledge-based insight, we can help you analyze the clinical landscape, stay informed of your competitors’ pipelines, and plan the development of your drug in a well-informed and strategic manner.

Our accrual enhancement initiatives and medical oncology support are the gold-standard of accrual enhancement services in the oncology space. Each project will be assigned a devoted team of clinical trial specialists led by an expert medical oncologist. These teams will not only interact with your physicians on a peer-to-peer basis, but can also identify and recommend sites, pinpoint challenges, and perform accrual workshops and investigator meetings to overcome barriers to accrual.

Performance-Based pricing

DAVA Oncology is not just any other “fee for service” accrual enhancement service provider. When we partner with you to achieve your accrual goals, we mean it. As a partner, we will not only work side-by-side with you on a daily basis, we will even share in the financial risk of our accrual enhancement initiatives. We have such faith in our services that we offer performance-based pricing to reward our mutual accrual success.